Targeted drug delivery system, Sem-VII, As per PCI Syllabus
AkshataJain17
1,836 views
30 slides
Oct 16, 2024
Slide 1 of 30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
About This Presentation
Targeted drug delivery implies for selective
and effective localization of pharmacologically
active moiety at pre-selected target(s)
therapeutic in concentration.
Size: 1.58 MB
Language: en
Added: Oct 16, 2024
Slides: 30 pages
Slide Content
Concept of targeted drug delivery
•The concept of targeted drug delivery system
given by "Paul Ehrlich", proposed drug
delivery as a "magic bullet“.
•Targeted drug delivery implies for selective
and effective localization of pharmacologically
active moiety at pre-selected target(s)
therapeutic in concentration.
•It restrict the entry of drug in non-targeted
cells, thus minimizing toxic effects.
Ideal characteristics of TDDS
Advantages
Disadvantages
• Rapid clearance of targeted systems.
• Immune reactions against intravenous administered carrier
systems.
• Insufficient localization of targeted systems into tumour cells.
• Diffusion and redistribution of released drugs.
• Requires highly sophisticated technology for the formulation.
• Requires skill for manufacturing storage, administration.
•Drug deposition at the target site may produce toxicity symptoms.
• Difficult to maintain stability of dosage form.
• Drug loading is usually law.
Components of Targeted Drug Delivery
System
Components Purpose
The active moiety To achieve the therapeutic
effect.
The carrier system (which
can be either soluble or
particulate)
To effect a favorable
distribution of the drug.
To protect the drug from
metabolism.
To protect the drug from
early clearance.
A "homing device“ To specifically target the
drug to the target cells or
target tissue
Practical steps for production
1.Immunize animal
2.Isolate spleen cells (containing antibody-producing B cell)
3.Fuse spleen cells with myeloma cell (using PEG)
4.Allow unfusedB cell to die
5.Add aminopterinto culture and kill unfusedmyeloma cells
6.Clone remaining cells (place 1 cell/well and allow each cell
to grow into a clones of cell)
7.Screen supernatant of each clone for presence of desired
antibody
8.Grow chosen clone of cells in tissue culture indefinitely
9.Harvest antibody from the culture.
10.$ 1000-2000 per mg
Applications
Major Applications:
(1) Diagnostic Applications
•Biochemical analysis
•Diagnostic Imaging
(2) Therapeutic Applications
• Direct use of MAbsas therapeutic agents
• MAbsas targeting agents.
(3) Protein Purification